![John Kirby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 98 982 $ in data 31/07/2026
John J.
Kirby is currently a Trustee at Delaware Museum of Natural History, Inc. since 2018 and Chief Financial Officer at Verrica Pharmaceuticals, Inc. starting in 2024.
Former positions include Regional Audit Director at AstraZeneca Pharmaceuticals LP from 2010 to 2012, Chief Accounting Officer & Vice President at Shire ViroPharma, Inc. from 2012 to 2014, Assistant Controller at Endo Pharmaceuticals, Inc. from 2014 to 2015, Chief Financial Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2019 to 2022, and Chief Financial Officer at Aceragen, Inc. from 2022 to 2023.
Education includes undergraduate studies at Villanova University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2026 | 18.962 ( 0,11% ) | 98 982 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Direttore Finanziario/CFO | 05/11/2024 |
Delaware Museum of Natural History, Inc.
 Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Direttore/Membro del Consiglio | 01/01/2018 |
| Società | Posizione | Fine |
|---|---|---|
| ACERAGEN, INC. | Direttore Finanziario/CFO | 28/04/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Direttore Finanziario/CFO | 01/09/2022 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Comptroller/Controller/Auditor | 01/10/2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Comptroller/Controller/Auditor | 01/07/2014 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Comptroller/Controller/Auditor | 01/08/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Delaware Museum of Natural History, Inc.
Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Consumer Services |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
